Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02HWL
|
||||
Former ID |
DIB020602
|
||||
Drug Name |
oleoyl-lysophosphatidylcholine
|
||||
Synonyms |
lysolecithin; LPC 18:1; lysophosphatidylcholine(18:1); OLPC
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540484] | ||
Structure |
Download2D MOL |
||||
Formula |
C26H52NO7P
|
||||
InChI |
InChI=1S/C26H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h12-13,25,28H,5-11,14-24H2,1-4H3/b13-12-/t25-/m1/s1
|
||||
InChIKey |
YAMUFBLWGFFICM-PTGWMXDISA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Agonist | [527346] | |
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.